|

Nivolumab-IRDye800 Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since September 2026

Pipeline

Early 1: 2

Top Sponsors

  • Vanderbilt-Ingram Cancer Center1
  • Eben Rosenthal1

Indications

  • Cancer2
  • High Grade Glioma (HGG) of the Brain With BRAF Aberration1
  • High Grade Gliomas1
  • High Grade Glioma (III or IV)1
  • HGG1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.